The Impact of Intravenous Lidocaine on ICP in Neurological Illness: A Systematic Review

Simple item page
dc.contributor.authorZeiler, F. A.
dc.contributor.authorSader, N.
dc.contributor.authorKazina, C. J.
dc.date.accessioned2015-09-21T14:30:58Z
dc.date.available2015-09-21T14:30:58Z
dc.date.issued2015-9-10
dc.date.updated2015-09-19T06:59:28Z
dc.description.abstractBackground. The goal of our study was to perform a systematic review of the literature to determine the effect that intravenous (IV) lidocaine had on ICP in patients with neurological illness. Methods. All articles are from MEDLINE, BIOSIS, EMBASE, Global Health, Scopus, Cochrane Library, the International Clinical Trials Registry Platform (inception to March 2015). The strength of evidence was adjudicated using both the Oxford and GRADE methodology. Results. Ten original articles were considered for the final review. There were 189 patients studied. Seven studies focused on prophylactic pretreatment with IV lidocaine to determine if there would be an attenuation of ICP spikes during stimulation, with 4 displaying an attenuation of ICP. Three studies focused on a therapeutic administration of IV lidocaine in order to determine ICP reduction effects. All therapeutic studies displayed a reduction in ICP. Conclusions. We cannot make a strong definitive recommendation on the effectiveness of IV lidocaine on the attenuation of ICP spikes during stimulation. There currently exists both Oxford 2b and GRADE B literature to support and refute the attenuation of ICP spikes with IV lidocaine during stimulation. There currently exists Oxford 2b, GRADE B evidence to support ICP reduction with lidocaine when used as a therapeutic agent.
dc.description.versionPeer Reviewed
dc.identifier.citationF. A. Zeiler, N. Sader, and C. J. Kazina, “The Impact of Intravenous Lidocaine on ICP in Neurological Illness: A Systematic Review,” Critical Care Research and Practice, vol. 2015, Article ID 485802, 12 pages, 2015. doi:10.1155/2015/485802
dc.identifier.urihttp://dx.doi.org/10.1155/2015/485802
dc.identifier.urihttp://hdl.handle.net/1993/30839
dc.language.rfc3066en
dc.rightsopen accessen_US
dc.rights.holderCopyright © 2015 F. A. Zeiler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.titleThe Impact of Intravenous Lidocaine on ICP in Neurological Illness: A Systematic Review
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
CCRP.2015.485802.xml
Size:
6.03 KB
Format:
Extensible Markup Language
Description:
Download
Thumbnail Image
Name:
CCRP.2015.485802.pdf
Size:
606.49 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.22 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
University of Manitoba Scholarship
Rady Faculty of Health Sciences Scholarly Works